Geode Capital Management’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$344K Sell
245,455
-641
-0.3% -$898 ﹤0.01% 3673
2025
Q1
$436K Buy
246,096
+4,659
+2% +$8.25K ﹤0.01% 3595
2024
Q4
$555K Buy
241,437
+11,620
+5% +$26.7K ﹤0.01% 3567
2024
Q3
$814K Buy
229,817
+59,370
+35% +$210K ﹤0.01% 3425
2024
Q2
$472K Buy
170,447
+100,688
+144% +$279K ﹤0.01% 3579
2024
Q1
$453K Buy
69,759
+12,471
+22% +$81.1K ﹤0.01% 3656
2023
Q4
$174K Buy
57,288
+775
+1% +$2.36K ﹤0.01% 3989
2023
Q3
$85.3K Buy
56,513
+1,467
+3% +$2.22K ﹤0.01% 4301
2023
Q2
$98.5K Buy
55,046
+247
+0.5% +$442 ﹤0.01% 4338
2023
Q1
$68.5K Buy
54,799
+10,311
+23% +$12.9K ﹤0.01% 4448
2022
Q4
$105K Buy
44,488
+167
+0.4% +$394 ﹤0.01% 4384
2022
Q3
$183K Buy
44,321
+668
+2% +$2.76K ﹤0.01% 4265
2022
Q2
$226K Buy
43,653
+264
+0.6% +$1.37K ﹤0.01% 4188
2022
Q1
$444K Buy
43,389
+289
+0.7% +$2.96K ﹤0.01% 3993
2021
Q4
$485K Buy
43,100
+1,953
+5% +$22K ﹤0.01% 4063
2021
Q3
$839K Buy
41,147
+2,806
+7% +$57.2K ﹤0.01% 3780
2021
Q2
$958K Buy
38,341
+9,754
+34% +$244K ﹤0.01% 3627
2021
Q1
$817K Buy
28,587
+17,121
+149% +$489K ﹤0.01% 3642
2020
Q4
$238K Buy
11,466
+4,071
+55% +$84.5K ﹤0.01% 3834
2020
Q3
$190K Buy
7,395
+306
+4% +$7.86K ﹤0.01% 3734
2020
Q2
$167K Buy
7,089
+1,555
+28% +$36.6K ﹤0.01% 3705
2020
Q1
$36K Buy
5,534
+939
+20% +$6.11K ﹤0.01% 3973
2019
Q4
$52K Buy
4,595
+1,845
+67% +$20.9K ﹤0.01% 4081
2019
Q3
$36K Hold
2,750
﹤0.01% 4097
2019
Q2
$39K Buy
2,750
+353
+15% +$5.01K ﹤0.01% 4105
2019
Q1
$93K Buy
+2,397
New +$93K ﹤0.01% 3911
2018
Q2
Sell
-896
Closed -$145K 4106
2018
Q1
$145K Buy
896
+132
+17% +$21.4K ﹤0.01% 3768
2017
Q4
$161K Sell
764
-107
-12% -$22.5K ﹤0.01% 3723
2017
Q3
$233K Buy
+871
New +$233K ﹤0.01% 3622